Sarah Warren

Senior Director, Research Technology and Business Development Planning, Gilead Sciences

Role: Associate

Site: CDL-Seattle

Stream: Computational Health

Sarah Warren is the Senior Director of Business Development at Cell Therapy Search and Evaluation at Gilead Sciences. Before her current role, she was the Senior Director of Research Tools and Business Development Planning at Kite Pharma, a Gilead company, where she supported the development of next-generation cell therapies. Sarah also serves on the board of directors for the Society of Immunotherapy of Cancer. She was a founder and director of research at Oncofactor Corp, a biotech startup focused on developing therapeutics that targeted novel immune checkpoints. Sarah has a PhD in immunology from the University of Washington and performed her graduate work at the Institute for Systems Biology.